Camostat Mesilate is a serine protease inhibitor with a wide range of activity. Using studies on the acute respiratory syndrome (SARS syndrome) coronavirus and the closely similar SARS-CoV-2 cell entry mechanism, it has been shown that Camostat mesilate may prevent SARS-CoV-2 cellular entrance and therefore prevent the transmission of the virus.
How does CAMOSTAT work?
Anthrax-CoV-2 is the virus that is causing the COVID-19 pandemic, and antivirals are required to fight the disease. Infection with the SARS-CoV-2 virus is prevented by the use of the clinically proven protease inhibitor Camostat mesylate, which works by inhibiting the virus-activating host tissue protease TMPRSS2. But there has been little research on the antiviral efficacy of Camostat mesylate intermediates or the possibility of viral resistance. Furthermore, it is yet unknown if Camostat mesylate has antiviral action in human lung tissue.
The cost of CAMOSTAT
The price of CAMOSTAT is USD 50 for 10 mg. But the prices may vary widely as per the pharmacy location.
Supplying CAMOSTAT Manufacturers and Suppliers
Establishing commercial ties
If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over this medicine offer with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.
To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen. CAMOSTAT manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.